Yunnan Jianzhijia Health-Chain Co., Ltd.

Symbol: 605266.SS

SHH

45.27

CNY

Market price today

  • 12.3363

    P/E Ratio

  • 3.1393

    PEG Ratio

  • 5.82B

    MRK Cap

  • 0.07%

    DIV Yield

Yunnan Jianzhijia Health-Chain Co., Ltd. (605266-SS) Financial Statements

On the chart you can see the default numbers in dynamics for Yunnan Jianzhijia Health-Chain Co., Ltd. (605266.SS). Companys revenue shows the average of 4050.3 M which is 0.216 % gowth. The average gross profit for the whole period is 1460.897 M which is 0.210 %. The average gross profit ratio is 0.365 %. The net income growth for the company last year performance is 0.107 % which equals 0.461 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Yunnan Jianzhijia Health-Chain Co., Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.800. In the realm of current assets, 605266.SS clocks in at 3939.389 in the reporting currency. A significant portion of these assets, precisely 935.601, is held in cash and short-term investments. This segment shows a change of -0.048% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 15.341, if any, in the reporting currency. This indicates a difference of 56.587% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 2155.284 in the reporting currency. This figure signifies a year_over_year change of 1.289%. Shareholder value, as depicted by the total shareholder equity, is valued at 2575.865 in the reporting currency. The year over year change in this aspect is 0.349%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 776.494, with an inventory valuation of 2165.71, and goodwill valued at 2242.77, if any. The total intangible assets, if present, are valued at 90.46. Account payables and short-term debt are 2802.99 and 779.27, respectively. The total debt is 2934.56, with a net debt of 2001.96. Other current liabilities amount to 601.91, adding to the total liabilities of 6826.08. Lastly, the referred stock is valued at 0, if it exists.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014

balance-sheet.row.cash-and-short-term-investments

3256.15935.6983.11621.6
443.3
328.4
357.6
245.9
204.5
237.8

balance-sheet.row.short-term-investments

180300
0
0
0
0
0
0

balance-sheet.row.net-receivables

2164.65776.5315.6391.7
328.5
337.3
282.7
263.4
225
222.7

balance-sheet.row.inventory

9253.272165.71121.2731.4
609.1
528.3
410.7
328.5
290.8
265.4

balance-sheet.row.other-current-assets

367.4461.67748.6
18.4
6.3
11.6
8.9
9.9
70

balance-sheet.row.total-current-assets

15142.323939.42496.92793.4
1399.2
1200.2
1062.5
846.6
730.2
795.9

balance-sheet.row.property-plant-equipment-net

10576.392644.21900.9376.9
368.2
349.7
319.5
207.2
186.4
100.3

balance-sheet.row.goodwill

9357.752242.8415.357.6
57.6
0
0
0
0
0

balance-sheet.row.intangible-assets

363.0790.544.733.5
29.8
27.1
19.1
18.1
17
16.1

balance-sheet.row.goodwill-and-intangible-assets

9720.822333.246091.1
87.4
27.1
19.1
18.1
17
16.1

balance-sheet.row.long-term-investments

63.8915.39.80
-232.9
-244.4
-237.6
0
0
0

balance-sheet.row.tax-assets

1111.632814.66
5.5
6.4
4.5
3.5
4.1
3.9

balance-sheet.row.other-non-current-assets

2024.68425.1331.9201.2
368.2
349.7
319.5
86.2
106.1
91.3

balance-sheet.row.total-non-current-assets

23497.415445.92717.3675.1
596.4
488.5
425
315
313.5
211.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0

balance-sheet.row.total-assets

38639.739385.35214.23468.5
1995.6
1688.7
1487.6
1161.6
1043.7
1007.5

balance-sheet.row.account-payables

9800.7628031724.41469
1174.8
973.1
865.4
720
690.2
633

balance-sheet.row.short-term-debt

6458.55779.3413.879.5
25.4
55.4
97.4
95.7
86.3
139.3

balance-sheet.row.tax-payables

256.3810058.836.4
58.8
71.7
42.9
20.8
18.5
19

balance-sheet.row.long-term-debt-total

6844.332155.3868.230.6
36
41.4
46.8
0
0.7
2

Deferred Revenue Non Current

48.412.613.18.5
15.1
15.3
8.9
4.7
4
2.7

balance-sheet.row.deferred-tax-liabilities-non-current

1103.7---
-
-
-
-
-
-

balance-sheet.row.other-current-liab

317.41601.91.81.6
7.8
83.2
9
10.9
4.6
4.4

balance-sheet.row.total-non-current-liabilities

9782.932600.9900.348
55.4
57.9
55.7
4.7
4.7
4.6

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

3624.77963.3842.9614.4
0
0
0
0
0
0

balance-sheet.row.total-liab

27603.546826.13321.21766.8
1417.8
1241.2
1146.9
915.4
865.1
857

balance-sheet.row.preferred-stock

108.4000
0
0
0
0
0
0

balance-sheet.row.common-stock

485.7799.269.553
39.8
39.8
39.8
39.8
39.8
39.8

balance-sheet.row.retained-earnings

4781.141012782.5628.7
385.4
261
166.8
80
18.5
4

balance-sheet.row.accumulated-other-comprehensive-income-loss

3012.6581.762.649.6
41.7
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

2718.131383.1995.1985.9
124.6
158.6
145.1
136.2
128.2
113.2

balance-sheet.row.total-stockholders-equity

11106.092575.91909.71717.2
591.5
459.4
351.6
256
186.4
157

balance-sheet.row.total-liabilities-and-stockholders-equity

38639.739385.35214.23468.5
1995.6
1688.7
1487.6
1161.6
1043.7
1007.5

balance-sheet.row.minority-interest

-69.89-16.7-16.7-15.4
-13.7
-11.9
-10.9
-9.8
-7.8
-6.5

balance-sheet.row.total-equity

11036.192559.218931701.7
577.8
447.5
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

38639.73---
-
-
-
-
-
-

Total Investments

193.8918.39.80
-232.9
-244.4
-237.6
0
0
0

balance-sheet.row.total-debt

14255.152934.61282110.1
61.4
96.8
144.2
95.7
87
141.3

balance-sheet.row.net-debt

111792002298.9-1511.5
-381.9
-231.6
-213.4
-150.2
-117.5
-96.5

Cash Flow Statement

The financial landscape of Yunnan Jianzhijia Health-Chain Co., Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 0.142. The company recently extended its share capital by issuing 0, marking a difference of 42.627 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 1048.1 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -2498650998.360 in the reporting currency. This is a shift of 2.450 from the previous year. In the same period, the company recorded 609.74, 2.4, and -120.4, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -155.04 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 1431.6, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014

cash-flows.row.net-income

390.37363.4299.3249.4
166.3
132.7
93.6
70.9
16.7
15.6

cash-flows.row.depreciation-and-amortization

596.62609.7481.725.3
22.8
16.4
15.9
0
10.4
11.2

cash-flows.row.deferred-income-tax

-63.87-17.1-14.2
3.7
0
0
0
0
0

cash-flows.row.stock-based-compensation

1.814.514-4.2
1.8
0
0
0
0
0

cash-flows.row.change-in-working-capital

-67.45-32.8-177.4-23.1
91.5
-1.7
51.6
0
-93.1
-10.3

cash-flows.row.account-receivables

161.57-311.9-89.8-108.9
8.8
0
0
0
0
0

cash-flows.row.inventory

-229.67-752-367.6-125.2
-76.3
-120.6
-83.9
0
-25.4
-62.8

cash-flows.row.account-payables

01048.1281206.8
155.3
0
0
0
0
0

cash-flows.row.other-working-capital

0.65-17.1-14.2
3.7
119
135.6
0
-67.7
52.5

cash-flows.row.other-non-cash-items

-61.96262.9127.965
51.5
45.8
44.4
-70.9
49.7
49.8

cash-flows.row.net-cash-provided-by-operating-activities

794.37000
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-324.98-780.7-385.5-133.1
-133.2
-103.9
-154.6
-48
-112.2
-62.9

cash-flows.row.acquisitions-net

-129.65-1706.5-321.2133.1
-38.7
104
154.6
48
112.2
62.9

cash-flows.row.purchases-of-investments

-185.95-800.9-1754.8-400
-115.4
-140.5
-285
-185
-147
-323

cash-flows.row.sales-maturities-of-investments

236.777871737.3396
115.5
140.7
285.4
185.2
212.3
268.3

cash-flows.row.other-investing-activites

18.212.40-133.1
0
-103.9
-154.6
-48
-112.2
-62.9

cash-flows.row.net-cash-used-for-investing-activites

-397.32-2498.7-724.2-137
-171.9
-103.7
-154.1
-47.8
-46.9
-117.6

cash-flows.row.debt-repayment

-347.79-120.4-79.4-25.4
-102.9
-97.4
-82.5
-128.4
-169.3
-161.3

cash-flows.row.common-stock-issued

000.30
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

00-0.30
0
0
0
0
0
0

cash-flows.row.dividends-paid

-204.31-155-124-4.5
-42.9
-33.9
-4.9
-5.7
-7.4
-20.5

cash-flows.row.other-financing-activites

-387.141431.6-462.3953
49.1
44.2
127.6
44.3
151.7
335.8

cash-flows.row.net-cash-used-provided-by-financing-activities

-504.871156.2-665.8923.2
-96.7
-87.1
40.2
-89.8
-25
154

cash-flows.row.effect-of-forex-changes-on-cash

-0.5000
0
0
0
0
0
-0.2

cash-flows.row.net-change-in-cash

-66.16-151.9-645.51102.8
69
2.4
91.6
7.6
-88.3
102.6

cash-flows.row.cash-at-end-of-period

1961.76573.8725.71371.2
268.4
199.4
197
105.4
94.8
183.1

cash-flows.row.cash-at-beginning-of-period

2027.92725.71371.2268.4
199.4
197
105.4
97.8
183.1
80.5

cash-flows.row.operating-cash-flow

794.371190.6744.4316.6
337.6
193.2
205.5
0
-16.3
66.4

cash-flows.row.capital-expenditure

-324.98-780.7-385.5-133.1
-133.2
-103.9
-154.6
-48
-112.2
-62.9

cash-flows.row.free-cash-flow

469.39409.9358.9183.6
204.4
89.3
51
-48
-128.5
3.5

Income Statement Row

Yunnan Jianzhijia Health-Chain Co., Ltd.'s revenue saw a change of 0.435% compared with the previous period. The gross profit of 605266.SS is reported to be 3257.92. The company's operating expenses are 2586.31, showing a change of 21.449% from the last year. The expenses for depreciation and amortization are 609.74, which is a 0.006% change from the last accounting period. Operating expenses are reported to be 2586.31, which shows a 21.449% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.259% year-over-year growth. The operating income is 522.08, which shows a 0.172% change when compared to the previous year. The change in the net income is 0.107%. The net income for the last year was 414.41.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014

income-statement-row.row.total-revenue

9216.969080.77514.45235
4466.4
3528.5
2765.9
2346.9
2053.8
1844.3
1667.1

income-statement-row.row.cost-of-revenue

5881.385822.84798.93359.1
2961.5
2288.3
1720.9
1475.4
1268.8
1151.8
1046.6

income-statement-row.row.gross-profit

3335.583257.92715.51875.8
1504.9
1240.2
1044.9
871.5
785.1
692.5
620.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

61.34---
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

2500.9---
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

3.040.6148.172.2
105.1
71.7
1.3
1.2
1.4
2.4
4.5

income-statement-row.row.operating-expenses

2707.132586.32129.61465
1188.6
995.1
847.7
727.1
683.1
651.1
578.3

income-statement-row.row.cost-and-expenses

8588.518409.16928.54824.1
4150
3283.4
2568.6
2202.5
1951.8
1802.9
1625

income-statement-row.row.interest-income

6.8277.57.7
2.1
1.2
1.3
1.2
-1.3
0
0

income-statement-row.row.interest-expense

124.27121.299.949.8
4.5
5.6
3.6
5.2
7
0
0

income-statement-row.row.selling-and-marketing-expenses

2500.9---
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-51.64-116.9-4.64.4
8.2
-2.9
-17.1
-15
-13.7
-13.6
-15.7

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

3.040.6148.172.2
105.1
71.7
1.3
1.2
1.4
2.4
4.5

income-statement-row.row.total-operating-expenses

-51.64-116.9-4.64.4
8.2
-2.9
-17.1
-15
-13.7
-13.6
-15.7

income-statement-row.row.interest-expense

124.27121.299.949.8
4.5
5.6
3.6
5.2
7
0
0

income-statement-row.row.depreciation-and-amortization

122.22748.7744.3550.8
53.7
38.2
16.4
15.9
13.3
10.4
11.2

income-statement-row.row.ebitda-caps

625.35---
-
-
-
-
-
-
-

income-statement-row.row.operating-income

510.99522.1445.4353.8
292.3
221.3
178.8
128.2
87
25.6
22.7

income-statement-row.row.income-before-tax

485.73522.7440.7358.2
300.5
218.4
180.1
129.4
88.3
27.9
26.5

income-statement-row.row.income-tax-expense

94.84108.277.359
51.1
52.1
47.4
35.8
19.4
11.2
10.9

income-statement-row.row.net-income

390.37414.4374.3300.5
251.1
168.1
133.6
94.7
70.9
18
17.4

Frequently Asked Question

What is Yunnan Jianzhijia Health-Chain Co., Ltd. (605266.SS) total assets?

Yunnan Jianzhijia Health-Chain Co., Ltd. (605266.SS) total assets is 9385265346.000.

What is enterprise annual revenue?

The annual revenue is 4884251320.000.

What is firm profit margin?

Firm profit margin is 0.362.

What is company free cash flow?

The free cash flow is 3.651.

What is enterprise net profit margin?

The net profit margin is 0.042.

What is firm total revenue?

The total revenue is 0.055.

What is Yunnan Jianzhijia Health-Chain Co., Ltd. (605266.SS) net profit (net income)?

The net profit (net income) is 414411521.000.

What is firm total debt?

The total debt is 2934555830.000.

What is operating expences number?

The operating expences are 2586312354.000.

What is company cash figure?

Enretprise cash is 780141461.000.